Skip to main content
. Author manuscript; available in PMC: 2016 Jul 15.
Published in final edited form as: Int J Cancer. 2015 Jan 28;137(2):448–462. doi: 10.1002/ijc.29388

Table 5.

Odds ratios (ORs)a,b for laryngeal cancer and corresponding confidence intervals (95% CIs) on non-alcohol energy-adjusted vitamin C intake quintiles, in strata of selected covariates. International Head and Neck Cancer Epidemiology (INHANCE) consortium.

II Quintile
OR (95% CI)
III Quintile
OR (95% CI)
IV Quintile
OR (95% CI)
V Quintile
OR (95% CI)
pstudiesc
Age (years)
  <55 0.63 (0.44–0.92) 0.44 (0.28–0.70) 0.39 (0.25–0.61) 0.48 (0.32–0.71) 0.281
  ≥ 55 0.62 (0.43–0.88) 0.55 (0.39–0.78) 0.52 (0.41–0.67) 0.53 (0.39–0.72) < 0.001
pstratad 0.729
Sex
  Female 0.76 (0.47–1.24) 0.57 (0.34–0.95) 0.42 (0.23–0.77) 0.69 (0.35–1.34) 0.002
  Male 0.60 (0.41–0.86) 0.52 (0.39–0.70) 0.48 (0.39–0.61) 0.48 (0.38–0.62) 0.002
pstratad 0.716
Education
  ≤high school graduate 0.56 (0.38–0.82) 0.47 (0.32–0.70) 0.53 (0.34–0.82) 0.48 (0.35–0.67) < 0.001
  ≥some college 0.78 (0.52–1.17) 0.57 (0.32–1.02) 0.53 (0.35–0.80) 0.58 (0.38–0.90) 0.119
pstratad 0.325
Geographic regione
  Europe 0.55 (0.33–0.9) 0.36 (0.24–0.54) 0.33 (0.24–0.44) 0.36 (0.21–0.63) < 0.001
  America 0.80 (0.54–1.20) 0.91 (0.68–1.22) 0.76 (0.56–1.02) 0.77 (0.57–1.04) 0.459
  Asia 0.82 (0.39–1.75) 1.54 (0.81–2.92) 0.50 (0.22–1.14) 1.35 (0.67–2.69) NE
pstratad 0.006
Body mass index
  <25 kg/m2 0.71 (0.53–0.97) 0.52 (0.34–0.79) 0.38 (0.25–0.60) 0.47 (0.3–0.74) 0.005
  ≥25 kg/m2 0.60 (0.39–0.90) 0.50 (0.33–0.75) 0.57 (0.41–0.79) 0.52 (0.34–0.79) < 0.001
pstratad 0.210
Tobacco consumption
  Never user 0.45 (0.18–1.08) 0.38 (0.15–0.98) 0.60 (0.27–1.34) 0.68 (0.32–1.46) 0.185
  Former user 0.58 (0.41–0.82) 0.64 (0.43–0.96) 0.43 (0.29–0.62) 0.66 (0.47–0.92) 0.144
Current user 0.55 (0.41–0.73) 0.59 (0.39–0.90) 0.49 (0.35–0.68) 0.55 (0.41–0.72) < 0.001
pstratad 0.845
Alcohol consumptionf
  Never/light drinker 0.65 (0.39–1.09) 0.72 (0.45–1.16) 0.61 (0.43–0.87) 0.76 (0.54–1.08) 0.227
Moderate drinker 0.51 (0.31–0.84) 0.38 (0.24–0.61) 0.43 (0.30–0.61) 0.39 (0.28–0.54) 0.004
Heavy drinker 0.55 (0.37–0.81) 0.43 (0.28–0.65) 0.35 (0.22–0.54) 0.38 (0.25–0.59) 0.831
pstratad 0.308
Tobacco and alcohol consumption combinedf
Never/former user -Never/light drinker 0.61 (0.34–1.06) 0.53 (0.28–0.99) 0.40 (0.23–0.71) 0.71 (0.44–1.16) 0.043
Current user- Never/light drinker 0.58 (0.31–1.09) 0.73 (0.39–1.38) 0.62 (0.39–0.99) 0.79 (0.49–1.28) 0.100
Never/former user -Moderate drinker 0.49 (0.28–0.86) 0.55 (0.27–1.12) 0.59 (0.34–1.00) 0.63 (0.38–1.06) 0.011
Current user -Moderate drinker 0.47 (0.31–0.72) 0.41 (0.23–0.73) 0.40 (0.24–0.66) 0.42 (0.22–0.84) <0.001
Never/former user - Heavy drinker 0.52 (0.29–0.94) 0.49 (0.27–0.92) 0.24 (0.11–0.51) 0.55 (0.29–1.06) 0.626
Current user -Heavy drinker 0.57 (0.34–0.95) 0.70 (0.33–1.46) 0.47 (0.20–1.08) 0.48 (0.26–0.90) 0.024
pstratad 0.907

ABBREVIATIONS: MSKCC: Memorial Sloan Kettering Cancer Center; NE: Not estimable.

a

Estimated from multiple logistic regression models adjusted for age, sex, education, race/ethnicity, study center, cigarette smoking status, cigarette intensity, cigarette duration, cigar smoking status, pipe smoking status, alcohol drinking intensity and the interaction between cigarette intensity and alcohol drinking intensity, when appropriate.

b

The I Quintile category was considered as the reference one.

c

P for heterogeneity among studies. When the p-value was less than 0.1 within strata, we reported the mixed-effects estimates derived from the corresponding generalized linear mixed model.

d

P for heterogeneity across strata. When, for a single stratification variable, fixed- and mixed-effects models were estimated within different strata, likelihood ratio tests for heterogeneity across strata were based on comparable mixed-effects models and therefore we re-fitted one or more mixed-effects models to replace the original fixed-effects ones. We consistently reported the corresponding stratum-specific mixed-effects models instead of the fixed-effects ones.

e

Europe included Italy Multicenter, Switzerland and Milan (2006–2009) studies. North America included Boston, Buffalo, Los Angeles, MSKCC, North Carolina (2002–2006), and US Multicenter studies. Asia included Japan study only. As Asia included Japan study only, there was no possibility to assess heterogeneity among studies in the Asia stratum.

f

The never/light drinker category included never drinkers and subjects who drinks less than 1 drink per day; the moderate drinker category included subjects drinking between 1 (included) and 5 drinks per day; the heavy drinker category included subjects drinking 5 drinks per day or more.

HHS Vulnerability Disclosure